Moreover, in a study conducted on 465 patients, p50 activation in ABC DLBCL was associated with poorer survival, despite significant correlations between p50 nuclear expression and downregulation of Bcl-2, p53, phospho-AKT, CXCR4 and Myc. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.